An engineered periosteum for efficient delivery of rhBMP-2 and mesenchymal progenitor cells during bone regeneration (2023)
Attributed to:
Engineering growth factor microenvironments - a new therapeutic paradigm for regenerative medicine
funded by
EPSRC
Abstract
No abstract provided
Bibliographic Information
Digital Object Identifier: http://dx.doi.org/10.1038/s41536-023-00330-2
PubMed Identifier: 37773177
Publication URI: http://europepmc.org/abstract/MED/37773177
Type: Journal Article/Review
Parent Publication: npj Regenerative Medicine
Issue: 1